Aft Pharmaceuticals Ltd (AFP.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Sales | 105,597 | 85,127 | 79,882 | 69,205 | 64,014 |
| Cost of Goods | 57,332 | 44,397 | 45,880 | 43,207 | 40,435 |
| Gross Profit | 48,265 | 40,730 | 34,002 | 25,998 | 23,579 |
| Operating Expenses | 38,079 | 36,649 | 45,411 | 43,368 | 37,421 |
| Operating Income | 10,186 | 4,081 | -11,409 | -17,370 | -13,842 |
| Interest Expense | 8,052 | 8,417 | 2,652 | 3,878 | 2,019 |
| Other Income | 10,743 | 2,077 | 1,395 | 2,918 | 2,552 |
| Pre-tax Income | 12,877 | -2,259 | -12,666 | -18,330 | -13,309 |
| Income Tax | 185 | 168 | 58 | 58 | -42 |
| Net Income Continuous | 12,692 | -2,427 | -12,724 | -18,388 | -13,267 |
| Net Income | $12,692 | $-2,427 | $-12,724 | $-18,388 | $-13,267 |
| EPS Basic Total Ops | 0.13 | -0.02 | -0.13 | -0.19 | -0.48 |
| EPS Basic Continuous Ops | 0.13 | -0.02 | -0.13 | -0.19 | -0.48 |
| EPS Diluted Total Ops | 0.13 | -0.02 | -0.13 | -0.19 | -0.48 |
| EPS Diluted Continuous Ops | 0.13 | -0.02 | -0.13 | -0.19 | -0.48 |
| EBITDA(a) | $21,710 | $6,477 | $-9,674 | $-14,126 | $-11,022 |